UNLOCKD Inc. Signs Binding LOI with NEXT10 to Form Expanded Health, Wellness, and Longevity Platform

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., announced on September 23, 2026, a binding Letter of Intent with NEXT10, Inc. (OTCID: NXTN) to create an expanded health, wellness, longevity, and human optimization platform. The transaction, valued at $0.0004 per issued and outstanding BFCH common share, will see NEXT10 contribute agreed revenue-producing businesses and assets to BFCH while acquiring an initial noncontrolling ownership position of up to 49%, along with representation on the BFCH Board of Directors. The agreement allows NEXT10 to increase its ownership to approximately 75% at a subsequent Control Closing, subject to BFCH’s planned audit and other closing conditions. BFCH will remain a separately traded public company.

John P. Gorst, Chief Executive Officer of BFCH, stated, “This is a major step forward in the strategy we began implementing at BFCH last year. NEXT10 is bringing operating assets, additional resources and a broader organization behind what we are building.” John B. Hayden, Chairman and CEO of NEXT10, noted, “This transaction gives NEXT10 a focused platform for expanding into health, wellness, longevity and human optimization while bringing additional operating assets and resources behind an existing management team and portfolio.” Dr. Jordan P. Balencic, Chairman and Chief Science Officer of BFCH, added, “Our vision is to build an integrated health, wellness, longevity and human optimization platform that can ultimately connect consumer products with technologies, testing, wellness services and scalable clinic concepts.”

BFCH’s current portfolio includes Ancient Extracts, EVERMIND, and 1ENERGY. The NEXT10 transaction is designed to expand beyond individual consumer brands, creating an interconnected operating platform where businesses can share products, distribution, customers, infrastructure, and operating resources. Management’s long-term objective is to build toward $100 million in enterprise value. The parties are actively finalizing the specific revenue-producing businesses and assets to be contributed, with additional details to be announced as the transaction advances.

For Texas businesses and the broader health and wellness industry, this deal signals a potential shift toward consolidation and integrated platforms that combine consumer products with services and technology. The involvement of NEXT10, a diversified holding company operating through Torreon Group, Inc., brings resources and scale that could accelerate growth and innovation in the longevity sector. As BFCH intends to complete an independent audit and seek qualification for the OTCQB Venture Market, the transaction may also enhance visibility and credibility among investors. Additional information is available through the company’s public disclosures, including the original release on www.newmediawire.com. NEXT10, Inc. is listed on the OTC Markets under the symbol NXTN, and its operating platform can be found at torreongroupinc.com.

The transaction remains subject to due diligence, definitive documentation, and other closing conditions. The $0.0004 per-share valuation is a negotiated term, and the $100 million enterprise value objective is a strategic goal, not a guarantee. No distribution of BFCH securities to NEXT10 shareholders has been declared or approved. Forward-looking statements are subject to risks and uncertainties.